Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH¿AEG¿SEPD¿SEOM¿GETECCU Mar Riveiro-Barciela; Sabela Carballal; Álvaro Díaz-González; Míriam Mañosa; Javier Gallego-Plazas; Joaquín Cubiella; Paula Jiménez-Fonseca; María Varela; Luis Menchén; Bruno Sangro; Ana Fernández-Montes; Francisco Mesonero; Miguel Ángel Rodríguez-Gandía; Fernando Rivera; María-Carlota Londoño;

Clinical and economic value of bulevirtide in the treatment of chronic hepatitis D M. Buti; JL. Calleja; MÁ. Rodríguez; R. Domínguez-Hernández; H. Cantero; N. Espinoza; MÁ. Casado;

Artificial intelligence-assisted identification and retrieval of chronic hepatitis C patients lost to follow-up in the health area of Pontevedra and O Salnés (Spain) Pablo Parada Vázquez; Santiago Pérez-Cachafeiro; Belen Castiñeira Dominguez; Juan Manuel González-Pérez; José Manuel Mera Calviño; Raquel Souto-Rodríguez; Yolanda Falagán Cachafeiro; Indhira Pérez-Medrano; Nuria Vázquez-Temprano; Matilde Trigo; Alba Carrodeguas; José Luis Gonzalez-Sánchez; Carmen Durán-Parrondo; Juan Turnes;